Study Finds Hospitals Reduce Pediatric Patient Length of Stay by 25% by Deploying Etiometry Risk Analytics

News and Press Releases

Results of a Multi-Center, Retrospective Cohort Analysis of All Neonates Admitted to the CICU at Boston Children’s Hospital and the Hospital for Sick Children, Toronto

BOSTON, December 19, 2017—Etiometry, a pioneering leader in next-generation patient monitoring, announced today that a study presented in the American Heart Association (AHA) Scientific Sessions 2017 demonstrates the capability of the Etiometry Platform to significantly reduce hospitals intensive care unit costs.

The Impact of a Real-Time Physiologic Data Analytic Index on Length of Stay in Neonates Following Surgery for Congenital Heart Disease abstract presented results from a retrospective study conducted in the first two hospitals that adopted Etiometry’s Inadequate Delivery of Oxygen (IDO2) Index. The study was co-authored by: Dr. Josh Salvin, Boston Children’s Hospital; Dr. Peter Laussen MBBS FCICM, The Hospital for Sick Children, Toronto; and Dr. Dimitar Baronov, PhD, Etiometry’s CTO. It demonstrates a statistically significant 25% reduction of length of stay (LOS) for the neonates admitted for cardiac intensive care in the two hospitals.

According to Etiometry’s COO Evan Butler, “There is a wide expectation in the clinical community that impactful information technology and actionable data analytics should bring much-needed reduction in hospital costs and improvement in patient outcomes. We are proud to see our Etiometry Platform leading the way in proving these expectations by demonstrating measurable positive impact in an especially vulnerable patient population.”

The Etiometry Platform consists of three software components: T3 Data Aggregation & Visualization, Risk Analytics Algorithms, and Quality Improvement System. They are integrated to support clinical use cases, such as meaningful workflow integration and streamlined measurement of care impact. For more information, send an email to info@etiometry.com and request the Etiometry ROI whitepaper.About Etiometry

Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.

For more information, visit www.etiometry.com.

We’d love to hear from you

Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.

Contact Us

Related

How Clinical Intelligence Software Supports ICU Decision-Making

In today’s increasingly complex ICU environments, clinicians are tasked with managing massive amounts of physiologic data under tight time constraints. Etiometry’s clinical intelligence software offers a powerful solution—an FDA-cleared, AI-driven clinical intelligence tool designed to augment clinical decision-making in critical care.  This article outlines Etiometry’s clinical intelligence software personalized hemodynamic and respiratory care strategies, improving […]

Keys to Success for AI Tool Adoption in Pediatric Critical Care

For successful adoption of AI tools in clinical care, health system and hospital clinicians should collaborate with the commercial developers of the technology. Read more about Dr. Gazit’s experience using Etiometry’s AI-driven clinical intelligence platform and how it supports confident decision-making in the ICU: HERE